About Synchron
Synchron is a company based in Brooklyn (United States) founded in 2016 by Rahul Sharma. It operates as a HealthTech. Synchron has raised $325 million across 6 funding rounds from investors including Metis, NIH and Khosla Ventures. Synchron offers products and services including Synchron BCI. Synchron operates in a competitive market with competitors including ONWARD, Nalu Medical, Atlantic Therapeutics, MyndTec and SpineX, among others.
- Headquarter Brooklyn, United States
- Founders Rahul Sharma
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Total Equity Funding
$325 M (USD)
in 6 rounds
-
Latest Funding Round
$200 M (USD), Series D
Nov 06, 2025
-
Investors
Metis
& 29 more
-
Employee Count
Not available
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Synchron
Synchron offers a comprehensive portfolio of products and services, including Synchron BCI.
A device enabling thought-controlled interaction with digital tools.
People of Synchron
Unlock access to complete
Funding Insights of Synchron
Synchron has successfully raised a total of $325M across 6 strategic funding rounds. The most recent funding activity was a Series D round of $200 million completed in November 2025. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in Synchron
Synchron has secured backing from 30 investors, including venture fund, institutional, and angel investors. Prominent investors backing the company include Metis, NIH and Khosla Ventures.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Venture capital firm focused on life science companies
|
Locked | Locked | Locked | |
|
Investment management and philanthropic ventures linked to Bezos Expeditions.
|
Locked | Locked | Locked | |
|
Tech-enabled businesses are funded by Greenoaks venture capital firm.
|
Locked | Locked | Locked |
Investor details for Synchron
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Synchron
Investment portfolio details for Synchron
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Synchron
Detailed financials for Synchron
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Synchron Comparisons
Peer comparison for Synchron
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Synchron
Synchron operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as ONWARD, Nalu Medical, Atlantic Therapeutics, MyndTec and SpineX, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Therapeutic devices for spinal cord injuries are developed and delivered.
|
|
| Locked | Locked | Locked |
Developer of a neurostimulation system for managing intractable chronic pain
|
|
| Locked | Locked | Locked |
Non-invasive wearable devices for pelvic floor strengthening are developed.
|
|
| Locked | Locked | Locked |
Functional electrical stimulation therapy is developed for upper limb paralysis.
|
|
| Locked | Locked | Locked |
Neuromodulation devices for neurological disorders are developed and offered.
|
Detailed competitors of Synchron
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Synchron
Complete news archive for Synchron
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Synchron
Synchron was founded in 2016 and raised its 1st funding round 1 year after it was founded.
Synchron is headquartered in Brooklyn, United States. It is registered at Brooklyn, New York, United States.
Synchron is a funded company, having raised a total of $325M across 6 funding rounds to date.
Synchron is engaged in developing brain-computer interface technology to assist individuals with movement limitations. The companys solutions are designed to enable thought-controlled interaction with digital devices, primarily targeting autonomy and social connection. Their innovative approach includes a minimally invasive endovascular procedure, avoiding traditional open brain surgery. Synchron operates within the healthcare and medical device sector, focusing on neurotechnology to address human body limitations.
Synchron's top competitors include ONWARD, Nalu Medical and MyndTec.
Synchron offers Synchron BCI.
Synchron has 30 investors. Key investors include Metis, NIH, Khosla Ventures, Arch Venture Partners, and University of Melbourne.